Countrywide management of pulmonary tuberculosis reverses increasing incidence

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 7, 2011, Pages 892-898

  Blöndal, Kai ^a,b   Viiklepp, P ^c   Blondal P ^a,d   Altraja, A ^e  

^a TARTU UNIVERSITY CLINICS   (Estonia)

^b Reykjavik Health Care Services Iceland   (Iceland)

^c NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e UNIVERSITY OF TARTU   (Estonia)

Author keywords

Estonia; MDR TB; National TB programme; PTB

Indexed keywords

TUBERCULOSTATIC AGENT;

AGED; ARTICLE; EPIDEMIC; ESTONIA; FEMALE; GROSS NATIONAL PRODUCT; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL STATUS; TREATMENT OUTCOME; TREND STUDY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; ANTITUBERCULAR AGENTS; DISEASE NOTIFICATION; ESTONIA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 79958694870     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0601     Document Type: Article

References (29)

1. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. WHO/HTM/TB2008.402. Geneva, Switzerland. WHO, 2008.
2. Laserson K F, Thorpe L E, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640-645. (Pubitemid 40826156)
3. World Health Organization. Multidrug and extensive drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: WHO, 2010.
4. World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
5. Krüüner A, Höffner S E, Sillastu H, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001; 39: 3339-3345. (Pubitemid 32830336)
6. Borrell S, Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1456-1466.
7. Gandhi N R, Moll A, Strum A W, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural areas of South Africa. Lancet 2006; 368: 1575-1580. (Pubitemid 44780738)
8. Shah N S, Wright A, Bai G H, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2007; 13: 380-387. (Pubitemid 46348124)
9. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to secondline drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55: 301-305.
10. Shean K P, Willcox P A, Siwendu S N, et al. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients. West Coast/Winelands, South Africa, 1992-2002. Int J Tuberc Lung Dis 2008; 12: 1182-1189.
11. Kwon Y S, Kim Y H, Suh G Y, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008; 47: 496-502.
12. Banerjee R, Allen J, Westenhouse J, et al. Extensively drug-resistant tuberculosis in California, 1993-2006. Clin Infect Dis 2008; 47: 450-457.
13. Keshavjee S, Gelmanova I Y, Farmer P E, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372: 1403-1409.
14. Leimane V, Leimanis J. Tuberculosis control in Latvia: integrated DOTS and DOTS-Plus programmes. Euro Surveill 2006; 11: 29-33.
15. Hawker I J, Bakhshi S S, Ali S, Farrington C P. Ecological analyses of ethic differences in relation between tuberculosis and poverty. BMJ 1999; 319: 1031-1034. (Pubitemid 29476431)
16. Santos M L S G, Vendramini S H F, Gazetta C E, Oliveira S A C, Villa T C S. Poverty: socioeconomic characterization at tuberculosis. Rev Lat Am Enfermagem 2007; 15: 762-767.
17. International Monetary Fund. World Economic Outlook Database - April 2010. Washington DC, USA: IMF, 2011. http://www.imf.org Accessed September 2010.
18. Gylfason T, Hochereiter E. Growing apart? A tale of two republics: Estonia and Georgia. International Monetary Fund Working Paper WP/08/235. Washington DC, USA: IMF, 2008. http://www.imf.org/external/pubs/ft/wp/2008/ wp08235.pdf Accessed September 2010.
19. Krüüner A, Danilovitsh M, Pehme L, et al. Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis 2001; 5: 170-176. (Pubitemid 32401862)
20. National Institute for Health Development. Structures and strategies related to HIV prevention. Tallinn, Estonia: NIHD, 2004. http://www.tai.ee Accessed May 2011.
21. Rüütel K, Lõhmus L. HIV and AIDS in figures 2006. Tallinn, Estonia: Tervise Areugu Instituut, 2007. http://www.tai.ee/failid/ HIVAIDS-in-figures-2006.pdf Accessed September 2010.
22. European Centre for Epidemiological Monitoring of AIDS (EuroHIV). HIV/AIDS surveillance in Europe: end-year report 2006. Saint-Maurice, France: Institut de Veille Sanitaire, 2007, No 75. http://www.eurohiv.org/reports/ report-75/pdf/report-eurohiv-75.pdf Accessed September 2010.
23. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009.
24. Murd M, Trummel A. HIV ja seotud nakkused arverdes 2009 sasta seisuga. Tallinn, Estonia: Health Board, Ministry of Social Affairs, TAI, 2010. http://www.tai.ee/failid/HIV-statistika-2009-06.2010.pdf Assessed September 2010. [Estonian]
25. Statistical Office of Estonia. Statistics Estonia. Tallinn, Estonia: Statistical Office of Estonia, 2010. http://pub.stat.ee Assessed September 2010.
26. European Commission. Eurostat. http://epp.eurostat.eceuropa.eu Accessed September 2010.
27. Dye C, Williams B G. Slow elimination of multidrug-resistant tuberculosis. Sci Transl Med 2009; 1: 3ra8.
28. Dye C. Drug-resistant tuberculosis: biology, epidemiology and control. In Gillespie S, ed. Antibiotic resistance: from genes to global prevalence. The Biomedical & Life Sciences Collection. London, UK: Henry Stewart Talks, 2009. http://hstalks.com/bio Accessed September 2010.
29. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.